These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 30642924)
1. Pharmacokinetic Data Are Predictive of Connolly KL; Eakin AE; Gomez C; Osborn BL; Unemo M; Jerse AE Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642924 [TBL] [Abstract][Full Text] [Related]
2. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Unemo M; Golparian D; Nicholas R; Ohnishi M; Gallay A; Sednaoui P Antimicrob Agents Chemother; 2012 Mar; 56(3):1273-80. PubMed ID: 22155830 [TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection. Nguyen PTT; Pham HV; Van DH; Pham LV; Nguyen HT; Nguyen HV BMC Infect Dis; 2022 Jul; 22(1):607. PubMed ID: 35810277 [TBL] [Abstract][Full Text] [Related]
4. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503 [TBL] [Abstract][Full Text] [Related]
5. Vincent LR; Kerr SR; Tan Y; Tomberg J; Raterman EL; Dunning Hotopp JC; Unemo M; Nicholas RA; Jerse AE mBio; 2018 Apr; 9(2):. PubMed ID: 29615507 [TBL] [Abstract][Full Text] [Related]
6. Emergence and evolution of internationally disseminated cephalosporin-resistant Neisseria gonorrhoeae clones from 1995 to 2005 in Japan. Shimuta K; Watanabe Y; Nakayama S; Morita-Ishihara T; Kuroki T; Unemo M; Ohnishi M BMC Infect Dis; 2015 Sep; 15():378. PubMed ID: 26381611 [TBL] [Abstract][Full Text] [Related]
7. Affinity of β-Lactam Antibiotics for Hiyama Y; Yamamoto S; Sato T; Ogasawara N; Masumori N; Takahashi S; Yokota SI Microb Drug Resist; 2024 Mar; 30(3):141-146. PubMed ID: 38215246 [TBL] [Abstract][Full Text] [Related]
8. In vitro activity of ertapenem versus ceftriaxone against Neisseria gonorrhoeae isolates with highly diverse ceftriaxone MIC values and effects of ceftriaxone resistance determinants: ertapenem for treatment of gonorrhea? Unemo M; Golparian D; Limnios A; Whiley D; Ohnishi M; Lahra MM; Tapsall JW Antimicrob Agents Chemother; 2012 Jul; 56(7):3603-9. PubMed ID: 22547617 [TBL] [Abstract][Full Text] [Related]
9. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013. Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P; Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284 [TBL] [Abstract][Full Text] [Related]
10. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population. Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681 [TBL] [Abstract][Full Text] [Related]
15. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. Whiley DM; Jacobsson S; Tapsall JW; Nissen MD; Sloots TP; Unemo M J Antimicrob Chemother; 2010 Dec; 65(12):2543-7. PubMed ID: 20940180 [TBL] [Abstract][Full Text] [Related]
16. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Ohnishi M; Golparian D; Shimuta K; Saika T; Hoshina S; Iwasaku K; Nakayama S; Kitawaki J; Unemo M Antimicrob Agents Chemother; 2011 Jul; 55(7):3538-45. PubMed ID: 21576437 [TBL] [Abstract][Full Text] [Related]
18. A Phase 1 Pharmacokinetic and Safety Study of Extended-Duration, High-dose Cefixime for Cephalosporin-resistant Neisseria gonorrhoeae in the Pharynx. Barbee LA; Nayak SU; Blumer JL; OʼRiordan MA; Gray W; Zenilman JM; Golden MR; Griffiss JM Sex Transm Dis; 2018 Oct; 45(10):677-683. PubMed ID: 29624558 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957 [TBL] [Abstract][Full Text] [Related]
20. Single-dose cefixime versus single-dose ceftriaxone in the treatment of antimicrobial-resistant Neisseria gonorrhoeae infection. Plourde PJ; Tyndall M; Agoki E; Ombette J; Slaney LA; D'Costa LJ; Ndinya-Achola JO; Plummer FA J Infect Dis; 1992 Oct; 166(4):919-22. PubMed ID: 1527431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]